Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus

出版年份 2009 全文链接

标题

作者

关键词

出版物

Volume 85, Issue 5, Pages 513-519

出版商

Springer Nature

发表日期

2009-01-07

DOI

10.1038/clpt.2008.250

参考文献

查看 2 条相关文献

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started